The use of highmolecular-weight hyaluronic acid in the treatment of osteoarthritis
Osteoarthritis (OA) is one of the most common diseases of the musculoskeletal system, affecting mainly people of old age. The management of OA requires combined therapy using pharmaceutical and nonpharmacological modalities, including hyaluronic acid (HA). Hylans are highmolecular-weight (HMW) HA de...
Saved in:
| Main Author: | S. G. Anikin |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2017-03-01
|
| Series: | Современная ревматология |
| Subjects: | |
| Online Access: | https://mrj.ima-press.net/mrj/article/view/740 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Use of hyaluronic acid preparations in the combination therapy of osteoarthritis
by: Yu. A. Olyunin
Published: (2016-06-01) -
Evaluation of the efficiency and safety of combined therapy with a symptomatic sustained-release drug and hyaluronic acid versus monotherapy with hyaluronic acid in patients with knee osteoarthritis
by: K. A. Berdyugin, et al.
Published: (2020-09-01) -
Evaluation of the efficacy of high molecular weight hyaluronic acid with chondroitin sulfate in post-traumatic knee osteoarthritis
by: E. I. Bialik, et al.
Published: (2024-08-01) -
Evaluation of the efficacy, tolerability, and safety of intra-articular hyaluronic acid in patients with knee osteoarthritis
by: S. G. Anikin, et al.
Published: (2017-09-01) -
INJECTABLE HYALURONIC ACID DRUGS FOR THE TREATMENT OF KNEE OSTEOARTHRITIS IN THE CONTEXT OF EVIDENCE-BASED MEDICINE
by: A. I. Petukhov, et al.
Published: (2018-05-01)